Cd(II) and As(III) bioaccumulation by recombinant Escherichia coli expressing oligomeric human metallothioneins

Journal of Hazardous Materials

Volumn 185, Issue 2-3, 2011, Pages 1605-1608

  Ma, Yao ^a   Lin, Jianqun ^a   Zhang, Chengjia ^a   Ren, Yilin ^b   Lin, Jianqiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Arsenic; Bioaccumulation; Cadmium; Heavy metal; Metallothionein

Indexed keywords

COEXPRESSED; DRY CELLS; E. COLI; EXPRESSION EFFICIENCY; GLUTATHIONE-S-TRANSFERASE; METAL BINDING CAPACITY; METAL-BINDING PROTEIN; METALLOTHIONEINS; PROTEIN STABILITY; RECOMBINANT E. COLI; RECOMBINANT ESCHERICHIA COLI;

ARSENIC; BIOACCUMULATION; BIOCHEMISTRY; CADMIUM; ESCHERICHIA COLI; METALS; OLIGOMERS; PROTEINS;

GENE EXPRESSION;

ARSENIC; CADMIUM; GLUTATHIONE TRANSFERASE; METALLOTHIONEIN; METALLOTHIONEIN 1A; UNCLASSIFIED DRUG;

ARSENIC; BIOACCUMULATION; CADMIUM; COLIFORM BACTERIUM; GENE EXPRESSION; PROTEIN; RECOMBINATION;

ARTICLE; BIOACCUMULATION; ESCHERICHIA COLI; GENE CONSTRUCT; GENE EXPRESSION; METAL BINDING; NONHUMAN; PROTEIN STABILITY;

ARSENIC; BASE SEQUENCE; BIOPOLYMERS; CADMIUM; DNA PRIMERS; ESCHERICHIA COLI; HUMANS; METALLOTHIONEIN; RECOMBINATION, GENETIC;

ESCHERICHIA COLI;

EID: 78649975294     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2010.10.051     Document Type: Article

References (27)

1. Viau M., Gastaldo J., Bencokova Z., Joubert A., Foray N. Cadmium inhibits non-homologous end-joining and over-activates the MRE11-dependent repair pathway. Mutat. Res. 2008, 654:13.
2. Macy J.M., Nunan K., Hagen K.D., Dixon D.R., Harbour P.J., Cahill M., Sly L.I. Chrysiogenes arsenatis gen. nov., sp. nov., a new arsenate-respiring bacterium isolated from gold mine wastewater. Intern. J. Syst. Bacteriol. 1996, 46:1153.
3. Wang S.L., Mulligan C.N. Occurrence of arsenic contamination in Canada: sources, behavior and distribution. Sci. Total Environ. 2006, 366:701.
4. Han F.-X., Su Y., Monts D.L., Plodinec M.J., Banin A., Triplett G.E. Assessment of global industrial-age anthropogenic arsenic contamination. Naturwissenschaften 2003, 90:395.
5. Bertin G., Averbeck D. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie 2006, 88:1549.
6. Templeton D.M., Liu Y. Multiple roles of cadmium in cell death and survival. Chem. Biol. Interact. 2010, 188:267.
7. Peters J.L., Perlstein T.S., Perry M.J., McNeely E., Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ. Res. 2010, 110:199.
8. Jarup L., Akesson A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238:201.
9. Nordberg G.F. Historical perspectives on cadmium toxicology. Toxicol. Appl. Pharmacol. 2009, 238:192.
10. Tseng C.-H., Huang Y.-K., Huang Y.-L., Chung C.-J., Yang M.-H., Chen C.-J., Hsueh Y.-M. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 2005, 206:299.
11. Rodriguze V.M., Jiménez-Capdeville M.E., Giordano M. The effects of arsenic exposure on the nervous system. Toxicol. Lett. 2003, 145:1.
12. Tapio S., Grosche B. Arsenic in the aetiology of cancer. Mutat. Res. 2006, 612:215.
13. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 2001, 176:127.
14. Litter M.I., Morgada M.E., Bundschuh J. Possible treatments for arsenic removal in Latin American waters for human consumption. Environ. Pollut. 2010, 158:1105.
15. Gecol H., Ergican E., Fuchs A. Molecular level separation of arsenic (V) from water using cationic surfactant micelles and ultrafiltration membrane. J. Membr. Sci. 2004, 241:105.
16. Kostal J., Yang R., Wu C.-H., Mulchandani A., Chen W. Enhanced arsenic accumulation in engineered bacterial cells expressing ArsR. Appl. Environ. Microbiol. 2004, 70:4582.
17. Kim S.K., Lee B.S., Wilson D.B., Kim E.K. Selective cadmium accumulation using recombinant Escherichia coli. J. Biosci. Bioeng. 2005, 99:109.
18. Deng X., Yi X.-E., Liu G. Cadmium removal from aqueous solution by gene-modified Escherichia coli JM109. J. Hazard. Mater. 2007, 139:340.
19. Singh S., Mulchandani A., Chen W. Highly selective and rapid arsenic removal by metabolically engineered Escherichia coli cells expressing fucus vesiculosus metallothionein. Appl. Environ. Microbiol. 2008, 74:2924.
20. Hamer D.H., Metallothionein Annu. Rev. Biochem. 1986, 55:913.
21. Su Y.-J., Lin J.-Q., Lin J.-Q., Hao D.-H. Bioaccumulation of Arsenic in recombinant Escherichia coli expressing human metallothionein. Biotechnol. Bioprocess Eng. 2009, 14:565.
22. Hong S.-H., Gohya M., Ono H., Murakami H., Yamashita M., Hirayama N., Murooka Y. Molecular design of novel metal-binding oligomeric human metallothioneins. Appl. Microbiol. Biotechnol. 2000, 54:84.
23. Berka T., Shatzman A., Zimmerman J., Strickler J., Rosenberg M. Efficient expression of the yeast metallothionein gene in Escherichia coli. J. Bacteriol. 1988, 170:21.
24. Cismowski M.J., Huang P.C. Purification of mammalian metallothionein from recombinant systems. Methods Enzymol. 1991, 205:312.
25. Yang F., Zhou M., He Z., Liu X., Sun L., Sun Y., Chen Z. High-yield expression in Escherichia coli of soluble human MT2A with native functions. Protein Express. Purif. 2007, 53:186.
26. Yalovegaa G., Smolentseva G., Soldatova A., Chanb J., Stillmanb M. Cd-metallothionein: analysis of local atomic structure. Nucl. Instrum. Methods Phys. Res., Sect. A 2007, 575:162.
27. Wang H., Zhang Q., Cai B., Li H.-Y., Sze K.-H., Huang Z.-X., Wu H.-M., Sun H.-Z. Solution structure and dynamics of human metallothionein-3 (MT-3). FEBS Lett. 2006, 580:795.